Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Passage Bio Inc (PASG)

Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Passage Bio Inc ONE COMMERCE SQUARE 2005 MARKET STREET 39TH FLOOR PHILADELPHIA PA 19103 USA

www.passagebio.com P: 267-866-0311

Description:

Passage Bio Inc. is a genetic medicines company. It is focused on developing transformative therapies for rare, monogenic central nervous system diseases. The company's principal product includes GM1 gangliosidosis, frontotemporal dementia and Krabbe disease which is in clinical stage. Passage Bio Inc. is based in Philadelphia, United States.

Key Statistics

Overview:

Market Capitalization, $K 83,176
Enterprise Value, $K 61,466
Shares Outstanding, K 61,612
Annual Sales, $ 0 K
Annual Net Income, $ -102,060 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,760 K
EBIT, $ -108,390 K
EBITDA, $ -106,700 K
60-Month Beta 1.28
% of Insider Shareholders 4.30%
% of Institutional Shareholders 53.48%
Float, K 58,963
% Float 95.70%
Short Volume Ratio 0.16

Growth:

1-Year Return 35.35%
3-Year Return -92.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 03/04/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -1.86
EPS Growth vs. Prev Qtr 38.78%
EPS Growth vs. Prev Year 40.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PASG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.12%
Return-on-Assets % -56.18%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.64
Book Value/Share 2.03
Interest Coverage -1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar